Biological characteristics of a new human glioma cell line transformed into A2B5+ stem cells

Molecular Cancer

Volumn 14, Issue 1, 2015, Pages

  Li, Yanyan ^a   Wang, Hangzhou ^a   Sun, Ting ^a   Chen, Jinming ^a   Guo, Lingchuan ^a   Shen, Haitao ^a   Du, Ziwei ^a   Zhou, Youxin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

A2B5; CD133; Glioma stem cells; Xenograft tumor

Indexed keywords

BIOLOGICAL MARKER; CD133 ANTIGEN; CD31 ANTIGEN; GANGLIOSIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIAL PRECURSOR GANGLIOSIDE; ISOCITRATE DEHYDROGENASE; KI 67 ANTIGEN; LONG UNTRANSLATED RNA; MICRORNA; NESTIN; NEURON GLIA ANTIGEN 2; PROTEIN S 100; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VIMENTIN;

ANIMAL TISSUE; ARTICLE; BIOCHIP; BRAIN TISSUE; CANCER CELL CULTURE; CARCINOGENICITY; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHROMOSOME NUMBER; CONTROLLED STUDY; CYTOLOGY; GENETIC TRAIT; GLIOMA CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OLIGODENDROGLIOMA; PHENOTYPE; PROTEIN EXPRESSION; STEM CELL; TRANSFORMED CELL LINE; TUMOR XENOGRAFT; ANIMAL; CANCER GRADING; CANCER STEM CELL; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; GLIOMA; KARYOTYPE; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR CELL CULTURE; TUMOR CELL LINE; XENOGRAFT; YOUNG ADULT;

MURINAE;

ANIMALS; BIOMARKERS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GLIOMA; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICRORNAS; NEOPLASM GRADING; NEOPLASTIC STEM CELLS; PHENOTYPE; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84926658879     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/s12943-015-0343-z     Document Type: Article

References (30)

1. Yan GN, Yang L, Lv YF, Shi Y, Shen LL, Yao XH, et al. Endothelial cells promote stem-like phenotype of glioma cells through activating hedgehog pathway [J]. J Pathol. 2014;3:6.
2. Wu TF, Chen JM, Chen SS, Chen GL, Wei YX, Xie XS, et al. Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors [J]. Zhonghua Zhong Liu Za Zhi. 2013;35(10):726-31.
3. Gangoso E, Thirant C, Chneiweiss H, Medina JM, Tabernero A. A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype [J]. Cell Death Dis. 2014;5:e1023.
4. Auf G, Jabouille A, Delugin M, Guérit S, Pineau R, North S, et al. High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor.[J]. BMC Cancer. 2013;13:597.
5. Henderson SD, Kimler BF, Morantz RA. Radiation therapy of 9L rat brain tumors [J]. Int J Radiat Oncol Biol Phys. 1981;7:497-502.
6. Ponten J. Neoplastic human glia cells in culture [M]. In: Human Tumor Cells in vitro [J]. New York: Plenum Press; 1975. p. 175-85.
7. Pavon LF, Marti LC, Sibov TT, Malheiros SM, Brandt RA, Cavalheiro S. Gamarra. In vitro analysis of neurospheres derived from glioblastoma primary culture: a novel methodology paradigm [J]. Front Neurol. 2014;4:214.
8. Fukaya R, Ohta S, Yamaguchi M, Fujii H, Kawakami Y, Kawase T, et al. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1 [J]. Cancer Lett. 2010;291:150-7.
9. Dou J, Gu N. Emerging strategies for the identification and targeting of cancer stem cells [J]. Tumour Biol. 2010;31:243-53.
10. Gilbert CA, Ross AH. Cancer stem cells: cell culture, markers, and targets for new therapies [J]. J Cell Biochem. 2009;108:1031-8.
11. Clément V, Marino D, Cudalbu C, Hamou MF, Mlynarik V, de Tribolet N, et al. Marker-independent identification of glioma-initiating cells [J]. Nat Methods. 2010;7:224-8.
12. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines [J]. Cancer Cell. 2006;9:391-403.
13. Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, Collins PV, et al. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours [J]. J Neurosci Methods. 2009;176:192-9.
14. Patru C, Romao L, Varlet P, Coulombel L, Raponi E, Cadusseau J, et al. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors [J]. BMC Cancer. 2010;10:66.
15. Pastrana E, Silva-Vargas V, Doetsch F. Eyes wide open: a critical review of sphere-formation as an assay for stem cells [J]. Cell Stem Cell. 2011;8:486-98.
16. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA, et al. Multicellular tumor spheroids: an underestimated tool is catching up again [J]. J Biotechnol. 2010;148:3-15.
17. Rappa G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, et al. Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets [J]. Exp Cell Res. 2008;314:2110-22.
18. Ghods AJ, Irvin D, Liu G, Yuan X, Abdulkadir IR, Tunici P, et al. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells [J]. Stem Cells. 2007;25:1645-53.
19. Wu A, Oh S, Wiesner SM, Ericson K, Chen L, Hall WA, et al. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties [J]. Stem Cells Dev. 2008;17:173-84.
20. Setoguchi T, Taga T, Kondo T. Cancer stem cells persist in many cancer cell lines [J]. Cell Cycle. 2004;3:414-5.
21. Thirant C, Bessette B, Varlet P, Puget S, Cadusseau J, Tavares Sdos R, et al. Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors [J]. PLoS One. 2011;6:e16375.
22. Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, et al. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma [J]. Stem Cells. 2009;27:980-7.
23. Kelly JJ, Stechishin O, Chojnacki A, Lun X, Sun B, Senger DL, et al. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens [J]. Stem Cells. 2009;27:1722-33.
24. Gremo F, Presta M. Role of fibroblast growth factor-2 in human brain: a focus on development [J]. Int J Dev Neurosci. 2000;18:271-9.
25. Soeda A, Inagaki A, Oka N, Ikegame Y, Aoki H, Yoshimura S, et al. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells [J]. J Biol Chem. 2008;283:10958-66.
26. Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J, Vasanji A, et al. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions [J]. Cell Death Dis. 2011;2:e200.
27. Ogden AT, Waziri AE, Lochhead RA, Fusco D, Lopez K, Ellis JA, et al. Identification of A2B5 + CD133- tumor-initiating cells in adult human gliomas [J]. Neurosurgery. 2008;62:505-14. discussion 514-505.
28. Tchoghandjian A, Baeza N, Colin C, Cayre M, Metellus P, Beclin C, et al. A2B5 cells from human glioblastoma have cancer stem cell properties [J]. Brain Pathol. 2010;20:211-21.
29. Vik-Mo EO, Sandberg C, Olstorn H, Varghese M, Brandal P, Ramm-Pettersen J, et al. Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions [J]. Neuro Oncol. 2010;12:1220-30.
30. Chandran S, Hunt D, Joannides A, Zhao C, Compston A, Franklin RJ. Myelin repair: the role of stem and precursor cells in multiple sclerosis [J]. Philos Trans R Soc Lond B Biol Sci. 2008;363:171-83.